EFG Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$6.48M Sell
10,149
-976
-9% -$592K 0.84% 27
2025
Q2
$5.96M Sell
11,125
-1,028
-8% -$492K 0.84% 26
2025
Q1
$5.1M Sell
12,153
-1,222
-9% -$531K 0.85% 25
2024
Q4
$5.53M Sell
13,375
-254
-2% -$111K 0.76% 32
2024
Q3
$6.88M Sell
13,629
-2,669
-16% -$1.3M 1.15% 11
2024
Q2
$7.94M Sell
16,298
-1,278
-7% -$642K 1.38% 7
2024
Q1
$9.49M Sell
17,576
-546
-3% -$298K 1.64% 8
2023
Q4
$10.1M Sell
18,122
-3,211
-15% -$1.51M 1.91% 4
2023
Q3
$9.33M Sell
21,333
-453
-2% -$226K 2.22% 2
2023
Q2
$10.9M Sell
21,786
-1,811
-8% -$868K 2.35% 2
2023
Q1
$11.8M Sell
23,597
-2,115
-8% -$1.01M 2.61% 1
2022
Q4
$10.6M Sell
25,712
-1,161
-4% -$451K 2.37% 2
2022
Q3
$8.76M Sell
26,873
-1,617
-6% -$594K 2.02% 3
2022
Q2
$9.99M Sell
28,490
-377
-1% -$154K 2.1% 3
2022
Q1
$15.8M Sell
28,867
-847
-3% -$446K 2.37% 2
2021
Q4
$19.6M Buy
+29,714
New +$18.7M 2.55% 1

Other funds holding IDXX

EFG Asset Management's IDXX Position: Q3 2025 in Review

EFG Asset Management reduced its Idexx Laboratories (IDXX) stake by 8.8% in Q3 2025, selling an estimated $592K and leaving 10,149 shares worth $6.48M. The position accounts for 0.84% of the portfolio, ranked #27.

EFG Asset Management first reported a position in IDXX in Q4 2021 and has held it in 16 quarters since. The position peaked at $19.6M in Q4 2021. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

  • EFG Asset Management held 10,149 shares of Idexx Laboratories worth $6.48M as of Q3 2025.
  • EFG Asset Management sold 976 Idexx Laboratories shares in Q3 2025, an estimated $592K.
  • Idexx Laboratories made up 0.84% of EFG Asset Management's portfolio in Q3 2025, its #27 holding.
  • EFG Asset Management first reported a position in Idexx Laboratories in Q4 2021 and has held it in 16 quarters since.
  • EFG Asset Management's Idexx Laboratories position peaked at $19.6M in Q4 2021.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on EFG Asset Management's 13F filing for Q3 2025, filed 3 Nov 2025.